Cargando…
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
Rheumatoid arthritis (RA) is a disease characterised by inflammation of synovial joints and poses a substantial healthcare burden on both the individual and society. One of the most significant shifts in the RA therapeutic landscape has occurred with the introduction of biological disease modifying...
Autores principales: | Findeisen, Kate E, Sewell, Julia, Ostor, Andrew J K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370108/ https://www.ncbi.nlm.nih.gov/pubmed/34413630 http://dx.doi.org/10.2147/BTT.S252575 |
Ejemplares similares
-
Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
por: Kiely, Patrick D. W., et al.
Publicado: (2012) -
Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
por: Negoescu, Andra F., et al.
Publicado: (2014) -
Treatment with Biologicals in Rheumatoid Arthritis: An Overview
por: Rein, Philipp, et al.
Publicado: (2017) -
Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review
por: Ostor, Andrew J., et al.
Publicado: (2021) -
Management of Rheumatoid Arthritis: An Overview
por: Radu, Andrei-Flavius, et al.
Publicado: (2021)